RHT.AX ASX
Resonance Health Limited
1W: +7.6%
1M: +22.4%
3M: +51.1%
YTD: +61.4%
1Y: +97.2%
3Y: +9.2%
5Y: -29.0%
A$0.07 ($0.05)
+0.00 (+5.63%)
Weekly Expected Move ±8.3%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$3M
+130.8% ▲
5Y CAGR: +19.8%
Capital Expenditures
$95K
+78.6% ▲
5Y CAGR: -24.9%
Free Cash Flow
$3M
+246.0% ▲
5Y CAGR: +29.2%
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$2M
+148.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$1M | -$780K | $169K | -$2M | $2M |
| Depreciation & Amort. | $429K | $436K | $498K | $965K | $954K |
| Stock-Based Comp. | $6K | $24K | $827K | $192K | $0 |
| Change in Working Capital | -$555K | $416K | -$88K | $2M | -$40K |
| Other Non-Cash Items | -$187K | -$229K | -$19K | -$182K | $454K |
| Operating Cash Flow | -$1M | -$157K | $1M | $1M | $3M |
| — Investing Activities — | |||||
| Capital Expenditures | -$704K | -$468K | -$229K | -$443K | -$301K |
| Acquisitions (Net) | $0 | $0 | -$4M | -$4M | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | -$148K | -$158K | $0 |
| Investing Cash Flow | -$704K | -$468K | -$4M | -$5M | -$301K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$70K | -$82K | $3M | -$287K | -$320K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$37K | $0 | -$164K | -$363K | -$278K |
| Financing Cash Flow | -$107K | -$82K | $3M | -$649K | -$598K |
| Net Change in Cash | $3M | -$422K | $493K | -$4M | $2M |
| Cash End of Period | $7M | $6M | $7M | $3M | $5M |
| Free Cash Flow | -$1M | -$625K | $1M | $805K | $3M |